Weight loss injections: what the term actually covers

This is the most useful sentence on the page, so it comes first: "weight loss injection" is not one category. Search the phrase and you will be shown two kinds of product that have nothing in common except a needle.

The first is a class of prescription medicines that act on appetite. They are hormone analogues — engineered versions of signals the gut already releases after a meal — given as an injection under the skin, weekly or daily, alongside support for diet and activity. They have been through licensing, they have trial data behind them, and a prescriber has to assess you before you can have one.

The second is injection lipolysis, usually sold as a "fat-dissolving" injection and given in aesthetic and beauty clinics. It is a local contouring procedure aimed at a small deposit of fat in one place. It is not a treatment for body weight, it has no licence for one, and in the UK the products used are generally unlicensed medicines. The two are confused constantly, and the confusion runs in the dangerous direction: people looking for a licensed medical treatment are shown an unlicensed cosmetic one.

Everything below separates them, and then separates the licensed medicines from each other — because that second distinction is where most people go wrong in a way that costs them months.

Four brand names account for almost all of the searching, and they do not all mean the same thing. One of them is not licensed for weight at all.

The category name has started to mislead in a second way. The word "injection" was accurate when every treatment in this class required one. It is no longer the whole picture, because there are now licensed oral options for weight management — tablets, not pens.

That matters practically. People who rule out treatment because they will not inject themselves are ruling out a route that no longer applies to everything, and they are usually doing it without being told. It matters commercially too, because the reader searching "weight loss injections" may be searching for the wrong thing: what they want is a treatment, and the delivery method is a preference, not a requirement.

So if the needle is the obstacle, say so during the assessment. It is a legitimate factor in choosing between treatments rather than a reason to abandon the conversation.

Injection lipolysis is sold under a number of product names and is given in cosmetic rather than medical settings. The pitch is local: a small deposit of fat under the chin, or on the flank, injected with a solution intended to break down the fat cells there.

Two things need saying plainly. It is not a treatment for body weight — no version of it claims to be, and anyone presenting it as one is misrepresenting it. And in the UK the products are generally not licensed medicines. In a ruling against a company promoting one such product, the Advertising Standards Authority recorded the MHRA’s confirmation that the product was an unlicensed medicinal product and so was not permitted to be used for cosmetic purposes such as fat dissolving — the only lawful route being as a "special" imported for an individual patient’s clinical need.

The harms are documented. In December 2023 the US Food and Drug Administration warned about unapproved fat-dissolving injections after reports of permanent scarring, serious infection, skin deformity, cysts and painful lumps, naming several products sold internationally. Only one injectable for reducing fat has ever been approved by the FDA, and it is approved for fat under the chin rather than for weight loss — and it is not licensed in the UK at all.

A third thing is sometimes sold in the same places and should not be confused with either: injections of vitamin B12, or of B vitamins with amino acids, marketed as "lipotropic" or "fat-burning" shots. They are not weight-management treatments and there is no good evidence that they cause weight loss in people who are not deficient. B12 injections have a real clinical use, which is treating B12 deficiency.

Having separated the categories, this is the distinction that decides what a reader should do next — and it is simpler than the marketing makes it.

Mechanism. Semaglutide and liraglutide act at the GLP-1 receptor. Tirzepatide acts at two, GIP as well as GLP-1. In the one head-to-head trial, the dual agonist produced the greater average reduction, which is a real finding and not the same thing as a prediction about an individual.

Frequency. Liraglutide is daily. Semaglutide and tirzepatide are weekly. Three hundred and sixty-five injections a year against fifty-two is the single commonest reason people stop a treatment that was otherwise working for them, and it is worth weighing before starting rather than discovering in month two.

Eligibility is the same for all of them in its structure, and it is set by the licence rather than by whoever is selling: a BMI of 30 or above, or 27 to under 30 with at least one listed weight-related condition. That is why a prescriber can say no, and why a service that never does should worry you.

What none of them differ on: they are all prescription-only, they all require an assessment, and none of them is a short course. Appetite returns when treatment stops, reliably, which makes what happens after the medicine the part worth asking about first.

The practical consequence of all of the above is a small change in how you open the conversation, and it saves a great deal of time.

Do not ask for "a weight loss injection", and do not ask for a brand you saw named. Say what you are actually asking for: an assessment for licensed weight-management treatment. That phrasing does three useful things. It cannot be answered with the diabetes medicine. It does not commit you to a delivery route you may not want. And it puts the question to the prescriber in the form they can answer, which is whether treatment is appropriate for you and which treatment that would be.

Then let them choose the molecule. That is the part of this they are for.

Briefly, because it is covered properly elsewhere and the answer depends on where you are. Every one of the licensed treatments is prescription-only, so every lawful supply runs through a prescriber who has assessed you — an NHS specialist service by referral, a registered online pharmacy, or a high street pharmacy against a private prescription.

Whether a prescription medicine may be sold at a distance at all is decided country by country, and the countries have decided differently. If you are outside the UK, the page for your market is the one to read, because a pharmacy acting lawfully in one country still cannot ship a prescription medicine into one that prohibits it.